MedTrace Logo

Evaluation of Tolsura When Used as Prophylaxis After Lung Transplantation

NCT04652050 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-04-24

No results posted yet for this study

Summary

This is a single-center, observational study of Tolsura PK sampling in lung transplant recipients

Conditions

  • Lung Transplant Infection

Interventions

DRUG

Tolsura

Patients fulfilling the inclusion criteria (see above) and placed on Tolsura for prophylaxis, and signed informed consent to participate in this study will be part of the study.

Sponsors & Collaborators

  • Hong Nguyen

    lead OTHER

Principal Investigators

  • Hong Nguyen, MD · UPMC and PITT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-04-01
Completion
2023-04-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04652050 on ClinicalTrials.gov